Overview

Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
To evaluate efficacy and safety of YH16410 versus rosuvastatin and telmisartan monotherapies in patients with hypertension and hyperlipidemia
Phase:
Phase 3
Details
Lead Sponsor:
Yuhan Corporation
Treatments:
Rosuvastatin Calcium
Telmisartan